Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8733276 | 0.98 | NOD1 (0.62) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL8576701 | 0.98 | NOD1 (0.62) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL28698069 | 0.92 | SLC6A5 (0.62) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL23961855 | 0.92 | NOD1 (0.58) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL18796577 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL18796595 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL3174603 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL8620977 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL8015739 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 | |
| SCHEMBL8015737 | 0.91 | SLC6A5 (0.64) | NOD1KMT2AMEN1FAAHMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170304240-A1 | NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170304240-A1 | NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS | EPOR, THPO, MCL1 | NOD1 4864/4885KMT2A 1922/4885MEN1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.